The Street has not taken it lightly. The stock was down 12 per cent to Rs 225 post-results and analysts raised concerns.
July has seen a revival in the monsoon and if the pace continues, Rallis’ performance can rebound. The company has attributed the pressures seen in the quarter to the farmer spending that was hit after a subdued rabi crop, as caution prevailed for the next crop season as well due to concerns on monsoon. In this backdrop, placement of crop protection products in the dealer network also got delayed. Rallis, which exports almost third of its produce, also saw its largest market Brazil getting hit by unprecedented drought (worst in last 80 years) and poor commodity prices leading to down-trading of agro products in the US.
While the dispatch of crop protection products to dealers has picked up after the initial rainfall, during the quarter some benefits were also seen to have accrued in Seed segment. Rallis’ seeds business did well and is estimated to have posted 20-23 per cent revenue and earnings growth. Although margins disappointed, the sales of Metahelix, a subsidiary of Rallis, were up 25 per cent and net profit 20 per cent year-on-year, as its hybrid seeds continued to gain market share.
After some good rainfall, Rallis remains optimistic.
V Shankar, managing director and CEO of Rallis India, said more than 62 per cent sowing has completed and company’s sales are picking up. The company has also launched two herbicides Parinda Grande for cotton crop and Mark used in soya bean, which have seen good response. Crop protection product sales are thereby expected to return to normalcy, as the September quarter is also generally strong.
While analysts at HSBC remain cautious, others believe that Rallis’ sales will revive. Analysts at Prabhudas Lilladher expect Rallis to deliver 21 per cent earnings CAGR (compound annual growth rate) over FY15-FY17, stable margins at about 16 per cent and high return on equity of 23 per cent. Analysts at IDFC Securities expect the new launches to drive a 12 per cent CAGR in the core pesticides business (52 per cent of FY14 revenues) over FY14-17. They also see increased traction in the domestic business, led by higher sale of non-pesticide agriculture inputs. With the share of high-margin new products increasing, they expect 80-150 basis points Ebitda margin expansion over the next three years.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)